HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myoung Ok Kim Selected Research

herbacetin

10/2017Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC.
1/2016Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Myoung Ok Kim Research Topics

Disease

24Neoplasms (Cancer)
05/2022 - 10/2006
8Carcinogenesis
01/2020 - 01/2007
7Melanoma (Melanoma, Malignant)
05/2022 - 05/2013
7Inflammation (Inflammations)
01/2022 - 08/2011
5Prostatic Neoplasms (Prostate Cancer)
09/2021 - 08/2011
4Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 06/2012
4Colonic Neoplasms (Colon Cancer)
03/2021 - 11/2011
4Skin Neoplasms (Skin Cancer)
10/2017 - 01/2012
3Type 2 Diabetes Mellitus (MODY)
08/2021 - 01/2018
3Arthritis (Polyarthritis)
12/2012 - 01/2012
3Experimental Arthritis
12/2012 - 01/2008
2Asthma (Bronchial Asthma)
01/2022 - 04/2012
2Periodontitis
01/2022 - 01/2020
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 06/2019
2Breast Neoplasms (Breast Cancer)
10/2019 - 10/2017
2Hepatitis
05/2015 - 09/2014
2Lung Neoplasms (Lung Cancer)
03/2014 - 12/2012
2Atherosclerosis
04/2012 - 01/2012
2Rheumatoid Arthritis
01/2012 - 01/2008
2Brain Neoplasms (Brain Tumor)
06/2006 - 03/2003
2Lymphoma (Lymphomas)
06/2006 - 03/2003
1Liver Neoplasms (Liver Cancer)
01/2022
1Eosinophilia
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Glioma (Gliomas)
01/2022
1Alveolar Bone Loss
01/2022
1Dermatitis
01/2022
1Rhinitis
01/2022
1Mouth Neoplasms (Oral Cancer)
07/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2021
1Body Weight (Weight, Body)
01/2021
1Bone Resorption
01/2020
1Cognitive Dysfunction
12/2019
1Amyloid Plaque
12/2019
1Alzheimer Disease (Alzheimer's Disease)
12/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019
1Weight Gain
04/2019
1Osteoporosis
09/2018

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
08/2021 - 08/2011
5CytokinesIBA
01/2022 - 01/2012
5Phosphotransferases (Kinase)IBA
07/2021 - 11/2011
4AntigensIBA
05/2022 - 06/2017
3shogaolIBA
01/2022 - 03/2014
3costunolideIBA
07/2021 - 01/2021
3Therapeutic UsesIBA
04/2021 - 01/2008
3p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 08/2011
3Amyloid (Amyloid Fibrils)IBA
12/2019 - 05/2015
3Protein Kinases (Protein Kinase)IBA
10/2017 - 08/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 09/2012
2Pharmaceutical PreparationsIBA
05/2021 - 01/2021
2Biological ProductsIBA
03/2021 - 01/2016
2ChemokinesIBA
01/2021 - 05/2015
2Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2021 - 06/2016
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2021 - 05/2013
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2021
2Interleukin-17 (Interleukin 17)IBA
01/2021 - 06/2019
2herbacetinIBA
10/2017 - 01/2016
23-hydroxyflavoneIBA
10/2017 - 09/2014
2Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
10/2017 - 01/2016
2Caspase 7IBA
11/2015 - 06/2012
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2013 - 01/2012
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2013 - 06/2012
2Superoxide DismutaseIBA
09/2012 - 01/2008
2Hormones (Hormone)IBA
08/2011 - 02/2007
2Tumor Viral Antigens (Large T Antigen)IBA
06/2006 - 03/2003
1ginsenoside Rh2IBA
05/2022
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2022
1Sirolimus (Rapamycin)FDA Link
01/2022
1Aluminum Hydroxide (Algeldrate)FDA Link
01/2022
1Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA
01/2022
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2022
1Anti-Allergic Agents (Antiallergic Agents)IBA
01/2022
1veratramineIBA
01/2022
1gingerolIBA
01/2022
1OvalbuminIBA
01/2022
1Transforming Growth Factor-beta Type I ReceptorIBA
09/2021
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
07/2021
1rheinIBA
04/2021
1Annexin A5IBA
03/2021
1Propidium (Propidium Iodide)IBA
03/2021
1LactonesIBA
01/2021
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021
1SesquiterpenesIBA
01/2021
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2021
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2021
1Imiquimod (Aldara)FDA LinkGeneric
01/2021
1VanadiumIBA
01/2020
1CathepsinsIBA
01/2020
1Cathepsin AIBA
01/2020
1Amyloid beta-PeptidesIBA
12/2019
1Glucose (Dextrose)FDA LinkGeneric
04/2019
1MicroRNAs (MicroRNA)IBA
04/2019
1Bortezomib (Velcade)FDA Link
09/2018

Therapy/Procedure

5Therapeutics
05/2021 - 01/2008
2Ligation
01/2022 - 01/2020
2Ovariectomy (Oophorectomy)
01/2022 - 09/2018
2Oral Administration
01/2016 - 11/2011
1Castration
09/2021
1Radiotherapy
05/2021
1Drug Therapy (Chemotherapy)
05/2021